# Thorsten Wirkes

> Thorsten Wirkes is a Series B investor at Bertelsmann Healthcare Investments backing Health Care. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Bertelsmann Healthcare Investments](https://shizune.co/investors/profile/bertelsmann-healthcare-investments)
- Location: New York, United States
- Total investments: 6
- Last investment: Aug 2026
- Lead investor: 17%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/thorstenwirkes/

Thorsten Wirkes is a Series B investor at Bertelsmann Healthcare Investments in New York focused on Health Care and Medical. Thorsten Wirkes is based out of New York and is the Co-Founder and Managing Director of Bertelsmann Healthcare Investments. Thorsten previously worked at Phare Health as an Investor. Thorsten Wirkes attended the WHU – Otto Beisheim School of Management.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 83% |
| Medical | 2 | 33% |
| Pharmaceutical | 2 | 33% |
| FinTech | 1 | 17% |
| Hospital | 1 | 17% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 3 | 50% |
| Seed | 2 | 33% |
| Series A | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 3 | 50% |
| Israel | 1 | 17% |
| United Kingdom | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| QuantHealth | Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $45M | Series B | Aug 04, 2026 |  |
| Andel | Andel platform strengthens pharmacy benefits by giving employers an affordable way to include GLP-1s and other brand name medications. | $4.5M | Seed | Oct 20, 2025 |  |
| Phare Health | Phare Health transforms the back office of healthcare, making it more efficient, accurate, and resillient. | $3.1M | Seed | Nov 22, 2023 |  |
| QuantHealth | Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $15M | Series A | Aug 30, 2023 |  |
| Paytient | Paytient helps people make better healthcare decisions by improving their ability to pay for care. We do this by bundling or embedding payment solutions like Paytient's Health Payment Account (HPA) or the Medicare Prescription Payment Plan alongside commercial, individual ACA, and Medicare plans. Armed with the power to decide how and whenthey pay for care, our users change their behavior in ways that improve their health and lower costs for everyone, which benefits the plan sponsor. By 2025, Paytient will serve 25M lives and 6,000 enterprise clients including leading employers and payers such as Anthem, Centene, Cigna, R.R. Donnelley, and Hyatt Hotels. The company has earned a 90 NPS and 4.9 stars on Trustpilot. | $33M | Series B | Jan 10, 2023 |  |
| SubjectWell | SubjectWell is the risk-free clinical trials marketplace for patient recruitment | $35M | Series B | Oct 18, 2022 |  |

6 of 6 investments shown.

## Co-investors
- [Cultivation Capital](https://shizune.co/investors/profile/cultivation-capital) — VC Fund, 2 deals together
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund, 2 deals together
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund, 2 deals together
- [Accenture Ventures](https://shizune.co/investors/profile/accenture-ventures) — VC Fund, 1 deal together
- [Artofin VC](https://shizune.co/investors/profile/artofin-vc) — VC Fund, 1 deal together
- [Asset Management Ventures (AMV)](https://shizune.co/investors/profile/asset-management-ventures) — VC Fund, 1 deal together

## About Bertelsmann Healthcare Investments

VC Fund

Bertelsmann Healthcare Investments (BHI) is a recently launched, independent transatlantic investment firm focused on healthcare, backed by Bertelsmann Investments. It targets high-growth, technology-driven healthcare companies, providing capital from early stages through expansion, along with sector expertise and networks.

1 contacts available at Bertelsmann Healthcare Investments.

| Name | Title | Profile |
| --- | --- | --- |
| Thorsten Wirkes | Co-Founder and Managing Director | https://shizune.co/investors/profile/thorsten-wirkes |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Thorsten Wirkes invest in?

Thorsten Wirkes invests primarily in Health Care, Medical and Pharmaceutical startups, most often at Series B and Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Thorsten Wirkes last invest?

The most recent investment recorded for Thorsten Wirkes closed in Aug 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co